Phase 2 Readout
PALI: Phase 2 Readout: pali-2108
September 30, 2026 · pali-2108. BioSniper AI can trace the company-impact path without requiring you to write the research question.
- Event date
- September 30, 2026
- Company
- PALISADE BIO, INC. (PALI)
- Drug
- pali-2108
BioSniper AIPage evidence connected
Prepared research question
What could this event change, and which evidence should be watched next?
Run cited research
Traceable citations · Unknowns marked
Phase 2 Readout~quarter
Phase 2 Readout: pali-2108
- Company
- PALISADE BIO, INC. (PALI)
- Drug
- pali-2108
- Indication
- Ulcerative Colitis (UC)